Evropska unija -
norveščina -
EMA (European Medicines Agency)
tecfidera
biogen netherlands b.v. - dimetylfumarat - multippel sklerose - immunsuppressive - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Norveška -
norveščina -
Statens legemiddelverk
actos 15 mg
orifarm as - pioglitazonhydroklorid - tablett - 15 mg
Norveška -
norveščina -
Statens legemiddelverk
actos 30 mg
orifarm as - pioglitazonhydroklorid - tablett - 30 mg
Norveška -
norveščina -
Statens legemiddelverk
somac 20 mg
orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 20 mg
Norveška -
norveščina -
Statens legemiddelverk
somac 20 mg
orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 20 mg
Norveška -
norveščina -
Statens legemiddelverk
somac 40 mg
orifarm as - pantoprazolnatriumsesquihydrat - enterotablett - 40 mg
Norveška -
norveščina -
Statens legemiddelverk
trileptal 300 mg
orifarm as - okskarbazepin - tablett, filmdrasjert - 300 mg
Norveška -
norveščina -
Statens legemiddelverk
trileptal 300 mg
orifarm as - okskarbazepin - tablett, filmdrasjert - 300 mg
Norveška -
norveščina -
Statens legemiddelverk
trileptal 600 mg
orifarm as - okskarbazepin - tablett, filmdrasjert - 600 mg
Norveška -
norveščina -
Statens legemiddelverk
trileptal 600 mg
orifarm as - okskarbazepin - tablett, filmdrasjert - 600 mg